Oppenheimer & Co’s BlackRock Health Sciences Trust BME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$294K Buy
6,849
+75
+1% +$2.98K ﹤0.01% 1486
2026
Q1
$261K Sell
6,774
-14
-0.2% -$577 ﹤0.01% 1451
2025
Q4
$279K Buy
6,788
+73
+1% +$2.88K ﹤0.01% 1297
2025
Q3
$250K Buy
6,715
+373
+6% +$13.6K ﹤0.01% 1458
2025
Q2
$231K Buy
6,342
+47
+0.7% +$1.7K ﹤0.01% 1447
2025
Q1
$243K Buy
6,295
+486
+8% +$19.3K ﹤0.01% 1370
2024
Q4
$220K Sell
5,809
-83
-1% -$3.31K ﹤0.01% 1418
2024
Q3
$247K Sell
5,892
-30
-0.5% -$1.25K ﹤0.01% 1326
2024
Q2
$242K Buy
5,922
+67
+1% +$2.67K ﹤0.01% 1270
2024
Q1
$243K Hold
5,855
﹤0.01% 1261
2023
Q4
$237K Sell
5,855
-250
-4% -$9.55K ﹤0.01% 1226
2023
Q3
$239K Sell
6,105
-575
-9% -$22.9K ﹤0.01% 1209
2023
Q2
$271K Buy
6,680
+409
+7% +$16.8K 0.01% 1197
2023
Q1
$263K Buy
6,271
+355
+6% +$14.9K 0.01% 1171
2022
Q4
$258K Buy
+5,916
New +$251K 0.01% 1140
2022
Q1
Sell
-5,816
Closed -$282K 1483
2021
Q4
$282K Sell
5,816
-290
-5% -$13.7K ﹤0.01% 1256
2021
Q3
$291K Buy
6,106
+1,426
+30% +$69.5K 0.01% 1239
2021
Q2
$227K Buy
+4,680
New +$224K ﹤0.01% 1373

Other funds holding BME

Oppenheimer & Co's BME Position: Q2 2026 in Review

Oppenheimer & Co increased its BlackRock Health Sciences Trust (BME) stake by 1.1% in Q2 2026, buying an estimated $2.98K and bringing the position to 6,849 shares worth $294K. The position accounts for ﹤0.01% of the portfolio, ranked #1486.

Oppenheimer & Co first reported a position in BME in Q2 2021 and has held it in 18 quarters since. 79 funds tracked by Wall St. Rank hold BME as of Q2 2026.

  • Oppenheimer & Co held 6,849 shares of BlackRock Health Sciences Trust worth $294K as of Q2 2026.
  • Oppenheimer & Co bought 75 BlackRock Health Sciences Trust shares in Q2 2026, an estimated $2.98K.
  • BlackRock Health Sciences Trust made up ﹤0.01% of Oppenheimer & Co's portfolio in Q2 2026, its #1486 holding.
  • Oppenheimer & Co first reported a position in BlackRock Health Sciences Trust in Q2 2021 and has held it in 18 quarters since.
  • 79 funds tracked by Wall St. Rank held BlackRock Health Sciences Trust as of Q2 2026.

Based on Oppenheimer & Co's 13F filing for Q2 2026, filed 3 Aug 2026.